Related Articles
Prostate‑specific antigen density and preoperative MRI findings as predictors of biochemical recurrence in high‑risk and very high‑risk prostate cancer
Real‑world data in elderly men from Yokosuka City 15 years after introducing prostate‑specific antigen‑based population screening.
Patients treated with radical prostatectomy with positive digital rectal examination findings in the intermediate‑risk group are prone to PSA recurrence
Diffuse large B-cell lymphoma: 10 years' real-world clinical experience with rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone
Expression of Toll-like receptor-9 is associated with poor progression-free survival in prostate cancer